UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice

Nature, 2005-04, Vol.434 (7034), p.782-786

2005

Volltextzugriff (PDF)

Antagonism of RANTES Receptors Reduces Atherosclerotic Plaque Formation in Mice

Circulation research, 2004-02, Vol.94 (2), p.253-261

2004

Volltextzugriff (PDF)

Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages

Atherosclerosis, 2006-09, Vol.188 (1), p.51-58

2006

Volltextzugriff (PDF)

Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo

Circulation (New York, N.Y.), 2005-08, Vol.112 (6), p.870-878

2005

Volltextzugriff (PDF)

Differential expression patterns of proinflammatory and antiinflammatory mediators during atherogenesis in mice

Arteriosclerosis, thrombosis, and vascular biology, 2004-12, Vol.24 (12), p.2339-2344

2004

Volltextzugriff (PDF)

Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins

Arteriosclerosis, thrombosis, and vascular biology, 2005-06, Vol.25 (6), p.1231-1236

2005

Volltextzugriff (PDF)

Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells

Cardiovascular research, 2003-09, Vol.59 (3), p.755-766

2003

Volltextzugriff (PDF)

Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis

Current drug targets. Cardiovascular & hematological disorders, 2005-04, Vol.5 (2), p.127-134

2005

Volltextzugriff (PDF)

Low dose oral cannobinoid therapy reduces progression of atherosclerosis in mice

Nature (London), 2005-04, Vol.434 (7034), p.782-786

2005

Volltextzugriff (PDF)

Corrigendum Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice

Nature, 2005-05, Vol.435 (7041), p.528-528

2005

Volltextzugriff (PDF)

Erratum: Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice

Nature (London), 2005-05, Vol.435 (7041), p.528-528

2005

Volltextzugriff (PDF)

Altered pattern of vascular connexin expression in atherosclerotic plaques

Arteriosclerosis, thrombosis, and vascular biology, 2002-02, Vol.22 (2), p.225-230

2002

Volltextzugriff (PDF)

Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice

Circulation (New York, N.Y.), 2003-02, Vol.107 (7), p.1033-1039

2003

Volltextzugriff (PDF)

PPARγ but not PPARα Ligands Are Potent Repressors of Major Histocompatibility Complex Class II Induction in Atheroma-Associated Cells

Circulation research, 2002-02, Vol.90 (3), p.356-362

2002

Volltextzugriff (PDF)

PPAR(gamma) but not PPAR(alpha) ligands are potent repressors of major histocompatibility complex class II induction in atheroma-associated cells

Circulation research, 2002-02, Vol.90 (3), p.356

2002

Volltextzugriff (PDF)

PPARgamma but not PPARalpha ligands are potent repressors of major histocompatibility complex class II induction in atheroma-associated cells

Circulation research, 2002-02, Vol.90 (3), p.356-362

2002

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(16)

Sprache

Englisch
(16)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Circulation Research
(4)
Nature
(4)
Arteriosclerosis, Thrombosis, And Vascular Biology
(3)
Circulation
(2)
Atherosclerosis
(1)
Cardiovascular Research
(1)
Current Drug Targets. Cardiovascular & Hematological Disorders
(1)

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice

Antagonism of RANTES Receptors Reduces Atherosclerotic Plaque Formation in Mice

Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages

Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo

Differential expression patterns of proinflammatory and antiinflammatory mediators during atherogenesis in mice

Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins

Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells

Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis

Low dose oral cannobinoid therapy reduces progression of atherosclerosis in mice

Corrigendum Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice

Erratum: Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice

Altered pattern of vascular connexin expression in atherosclerotic plaques

Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice

PPARγ but not PPARα Ligands Are Potent Repressors of Major Histocompatibility Complex Class II Induction in Atheroma-Associated Cells

PPAR(gamma) but not PPAR(alpha) ligands are potent repressors of major histocompatibility complex class II induction in atheroma-associated cells

PPARgamma but not PPARalpha ligands are potent repressors of major histocompatibility complex class II induction in atheroma-associated cells

Suchergebnisse filtern